Health
This is to provide Latest HealthNews around the globe
-
FDA recalls commonly prescribed ADHD medication over failed lab tests
A commonly prescribed medication for attention-deficit hyperactivity disorder (ADHD) has been recalled nationwide after failing to meet dissolution standards during laboratory testing. According to an enforcement report from the Food and Drug Administration (FDA), Sun Pharmaceutical Industries Inc. initiated a voluntary recall on Oct. 28 for its lisdexamfetamine dimesylate capsules, a generic alternative to the brand-name drug Vyvanse. The recall…
Read More » -
‘Crazy’ JD Vance Calls Common Pain Medication Ibuprofen ‘Useless’ While Cozying Up to MAHA
Vice President JD Vance revealed that he thinks Ibuprofen, a common pain medication, is “useless,” admitting he’s “crazy” for a belief he said was in line with “MAHA style.” While speaking with Health and Human Services Secretary Robert F. Kennedy Jr. at a Nov. 12 MAHA summit in Washington, D.C., Vance opened up about “the one way” he is “more…
Read More » -
A better chance to prevent diabetes
Credit: Pixabay/CC0 Public Domain An elevated blood glucose level one hour after the oral glucose tolerance test (OGTT) signals a critical metabolic state—even before prediabetes. Affected individuals respond particularly well to lifestyle interventions. This value could become a new clinically relevant biomarker—and enable more targeted, earlier prevention of type 2 diabetes. This is the conclusion reached by a team from…
Read More » -
Study reveals challenges in accessing wheelchairs through Medicare-listed suppliers
In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: Published today in Mayo Clinic Proceedings, a University of Minnesota Medical School research team found that access to wheelchairs through Medicare-listed suppliers is inconsistent and often challenging. Using a secret-shopper approach where researchers posed as patients seeking…
Read More » -
Queer Eye’s Tan France to front Lilly obesity campaign
Eli Lilly has enlisted the aid of Tan France, fashion guru on the wildly popular US makeover show Queer Eye, in a campaign that seeks to fight bias and stigma in obesity through clothing and personal narratives. The new initiative – called Changing the Thread Collection – aims to reframe obesity as a chronic disease “deserving of understanding and treatment”…
Read More » -
Bringing Health and Sports Together at SONA Softball Championship
Imagine being an athlete ready to compete at the highest level, but you’re distracted by a throbbing mouth from tooth pain. Or trying to run down the track in shoes that aren’t the right size for you. Or maybe standing at home plate ready to hit the softball, but not being able to see it because you need new glasses.…
Read More » -
Simple blood test may be a better guide treatment for ovarian cancer
In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: More than 300,000 women are diagnosed with ovarian cancer globally each year. The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University of Sydney NHMRC Clinical Trials Centre,…
Read More » -
Osteoporosis alert issued over popular medication as doctor warns ‘they’re not good for bones’
A new initiative supported by the Queen is encouraging Britons to spend just three minutes checking if they’re at risk of developing osteoporosis. The online assessment was created by the Royal Osteoporosis Society to help millions get diagnosed and treated sooner. It comes as around 3.5 million people across the UK are thought to be living with osteoporosis, yet many…
Read More » -
LSD microdosing reduces depression scores without major side effects, clinical trial finds
Credit: Unsplash/CC0 Public Domain University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating Scale (MADRS) scores reduced by 59.5% at the end of treatment and sustained to six months. Major depressive disorder affects about 5% of the global population and existing antidepressants can have slow…
Read More » -
What influencers and critics aren’t telling you about antidepressants
On social media, influencers tout them as lifestyle medications that can turn around your life. But Health Secretary Robert F. Kennedy Jr. has branded SSRIs—or selective serotonin reuptake inhibitors, the most common class of antidepressants—as more addictive than heroin and linked them to violent episodes such as a recent church shooting in Minnesota. He’s said the government is launching studies…
Read More »